eQcell Inc. is Canada’s premier clinical-stage regenerative medicine company addressing conditions and diseases affecting sporting and domestic animals globally for which current treatments are ineffective, not fully effective, or palliative. eQcell has developed allogeneic equine cord blood stem cells as well as canine adipose-derived mesenchymal stromal cells designed to provide veterinarians around the world with off-the-shelf therapeutics with increased efficacy and predictability over the current, laborious and expensive autologous stem cell treatments that extract, expand and re-inject a horse's own cells.